# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, Regulation 214A: Amendment of regulation 294 (general requirements)


In regulation 294, after paragraph (4) insert—
“(5) In the case of an advertisement which relates to a medicinal product for sale or supply—
(a) in Northern Ireland only, the requirements of this regulation must be met in relation to the product for sale or supply in Northern Ireland,
(b) in Great Britain only, the requirements of this regulation must be met in relation to the product for sale or supply in Great Britain, and
(c) in the whole of the United Kingdom, the requirements of this regulation must be met in relation to both—
(i) the product for sale or supply in Great Britain, and
(ii) the product for sale or supply in Northern Ireland.”.

---
Source: https://www.legislation.gov.uk/uksi/2019/775/regulation/214A (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2019/regulation-214A
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.